The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...
In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...
Bloomberg on MSN2mon
Moderna’s Bancel Steps Down as Sales Chief, Keeps CEO Role(Bloomberg) -- Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar ...
The challenge of maintaining the earlier growth achieved by US mRNA medicines specialist Moderna through its COVID vaccine ...
With COVID-19 revenues now shrinking fast, Moderna chief executive Stéphane Bancel has taken the decision to rein in spending and reduce the number of active development programmes, which have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback